In addition, a global metabolite profiling analysis identified NPalGly as the major palmitate-derivative produced in HER2/neu-positive breast cancer cells, suggesting NPalGly implication in the systemic responses to the tumor as well as in the etiology of breast cancer [72]. This evidence concerns the gene ERBB2 and neoplasm.